Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Neurodegenerative disease

MRI biomarkers — a precision medicine tool in neurology?

Nature Reviews Neurology volume 12, pages 323–324 (2016)Cite this article

Subjects

Two new studies highlight the potential of neuroimaging to aid the differential diagnosis of neurodegenerative disease, for both clinical practice and emerging trials. Although this approach holds great promise, meaningful implementation of neuroimaging as part of a tailored precision medicine strategy may require additional imaging and non-imaging biomarkers.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Harper, L. et al. MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases. Brain 139, 1211–1225 (2016).

    Article  Google Scholar 

  2. Koikkalainen, J. et al. Differential diagnosis of neurodegenerative diseases using structural MRI data. NeuroImage Clin. http://dx.doi.org/10.1016/j.nicl.2016.02.019, (2016).

  3. Beach, T. G., Monsell, S. E., Phillips, L. E. & Kukull, W. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010. J. Neuropathol. Exp. Neurol. 71, 266–273 (2012).

    Article  Google Scholar 

  4. Toledo, J. B. et al. CSF biomarkers cutoffs: the importance of coincident neuropathological diseases. Acta Neuropathol. 124, 23–35 (2012).

    Article  CAS  Google Scholar 

  5. Irwin, D. J. et al. Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine. Acta Neuropathol. 129, 469–491 (2015).

    Article  Google Scholar 

  6. McMillan, C. T. et al. The power of neuroimaging biomarkers for screening frontotemporal dementia. Hum. Brain Mapp. 35, 4827–4840 (2014).

    Article  Google Scholar 

  7. Schöll, M. et al. PET imaging of tau deposition in the aging human brain. Neuron 89, 971–982 (2016).

    Article  Google Scholar 

  8. Irwin, D. J. et al. Comparison of cerebrospinal fluid levels of tau and Aβ1–42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platforms. Arch. Neurol. 69, 1018–1025 (2012).

    Article  Google Scholar 

  9. McMillan, C. T. et al. Genetic and neuroanatomic associations in sporadic frontotemporal lobar degeneration. Neurobiol. Aging 35, 1473–1482 (2014).

    Article  CAS  Google Scholar 

  10. Whitwell, J. L. et al. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain 135, 794–806 (2012).

    Article  Google Scholar 

Download references

Acknowledgements

C.T.M. receives research support from the NIH (AG043503, AG010124), the Dana Foundation and the Wyncote Foundation, and joint support from the Alzheimer's Association and the Michael J. Fox Foundation (BAND-14-338181).

Author information

Authors and Affiliations

  1. Corey T. McMillan is in the Department of Neurology, Penn Frontotemporal Degeneration Center, Hospital of the University of Pennsylvania, 3400 Spruce Street, 3 West Gates, Philadelphia, Pennsylvania 19104, USA.,

    Corey T. McMillan

Authors
  1. Corey T. McMillan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Corey T. McMillan.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

McMillan, C. MRI biomarkers — a precision medicine tool in neurology?. Nat Rev Neurol 12, 323–324 (2016). https://doi.org/10.1038/nrneurol.2016.51

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2016.51

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing